|
US5244792A
(en)
|
1984-04-06 |
1993-09-14 |
Chiron Corporation |
Expression of recombinant glyoprotein B from herpes simplex virus
|
|
JPH0668B2
(ja)
|
1985-08-30 |
1994-01-05 |
財団法人化学及血清療法研究所 |
単純ヘルペスウイルス遺伝子が組込まれた組換えプラスミド
|
|
GB8918616D0
(en)
|
1989-08-15 |
1989-09-27 |
Univ Glasgow |
Herpes simplex virus type 1 mutant
|
|
US5725871A
(en)
|
1989-08-18 |
1998-03-10 |
Danbiosyst Uk Limited |
Drug delivery compositions comprising lysophosphoglycerolipid
|
|
US5707644A
(en)
|
1989-11-04 |
1998-01-13 |
Danbiosyst Uk Limited |
Small particle compositions for intranasal drug delivery
|
|
US5466468A
(en)
|
1990-04-03 |
1995-11-14 |
Ciba-Geigy Corporation |
Parenterally administrable liposome formulation comprising synthetic lipids
|
|
US5849571A
(en)
|
1990-10-10 |
1998-12-15 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Latency active herpes virus promoters and their use
|
|
US5849572A
(en)
|
1990-10-10 |
1998-12-15 |
Regents Of The University Of Michigan |
HSV-1 vector containing a lat promoter
|
|
US5399363A
(en)
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
|
US5756353A
(en)
|
1991-12-17 |
1998-05-26 |
The Regents Of The University Of California |
Expression of cloned genes in the lung by aerosol-and liposome-based delivery
|
|
ES2105262T3
(es)
|
1992-05-18 |
1997-10-16 |
Minnesota Mining & Mfg |
Dispositivo de suministro de farmaco a traves de las mucosas.
|
|
US5658724A
(en)
|
1992-07-31 |
1997-08-19 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Herpes simplex virus strains deficient for the essential immediate early genes ICP4 and ICP27 and methods for their production, growth and use
|
|
US5804413A
(en)
|
1992-07-31 |
1998-09-08 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Herpes simplex virus strains for gene transfer
|
|
US5879934A
(en)
|
1992-07-31 |
1999-03-09 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Herpes simplex virus strains for gene transfer
|
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
GB9415319D0
(en)
|
1994-07-29 |
1994-09-21 |
Medical Res Council |
HSV viral vector
|
|
GB9415369D0
(en)
|
1994-07-29 |
1994-09-21 |
Lynxvale Ltd |
Mutant virus
|
|
IE80468B1
(en)
|
1995-04-04 |
1998-07-29 |
Elan Corp Plc |
Controlled release biodegradable nanoparticles containing insulin
|
|
US6261552B1
(en)
|
1997-05-22 |
2001-07-17 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Herpes simplex virus vectors
|
|
GB9700411D0
(en)
|
1997-01-10 |
1997-02-26 |
Univ London |
Eukaryotic gene expression cassette and uses thereof
|
|
US6071742A
(en)
|
1997-03-05 |
2000-06-06 |
Board Of Regents Of The University Of Nebraska |
Coxsackie virus as a vector for delivery of anti-inflammatory cytokines
|
|
US5998174A
(en)
|
1997-05-12 |
1999-12-07 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Multigene vectors
|
|
AU8605598A
(en)
|
1997-07-31 |
1999-02-22 |
University Of Pittsburgh |
Targeted hsv vectors
|
|
AU742757C
(en)
|
1997-12-17 |
2007-05-17 |
Immunex Corporation |
Cell surface glycoproteins associated with human B cell lymphomas - ULBP, DNA and polypeptides
|
|
GB9810423D0
(en)
|
1998-05-15 |
1998-07-15 |
Cancer Res Campaign Tech |
Ionizing radiation or diathermy-switched gene therapy vectors and their use in antitumour therapy
|
|
EP1002864A1
(en)
|
1998-11-10 |
2000-05-24 |
Universita' degli studi di Bologna |
HIgR and related V domain for the manufacture of a medicament for preventing or treating HSV-1, HSV-2 and BHV infections
|
|
US6897057B1
(en)
|
1999-08-31 |
2005-05-24 |
The General Hospital Corporation |
Cell-specific and/or tumor-specific promoter retargeting of herpes γ 34.5 gene expression
|
|
GB9930418D0
(en)
|
1999-12-22 |
2000-02-16 |
Neurovex Ltd |
Replication incompetent herpes virus vectors
|
|
CA2441663C
(en)
|
2001-03-27 |
2013-01-22 |
Medigene, Inc. |
Viral vectors and their use in therapeutic methods
|
|
WO2002088327A1
(en)
|
2001-04-06 |
2002-11-07 |
Mount Sinai School Of Medicine Of New York University |
Methods for viral oncoapoptosis in cancer therapy
|
|
CA2462790A1
(en)
|
2001-10-04 |
2003-04-10 |
Immunex Corporation |
Ul16 binding protein 4
|
|
KR100900249B1
(ko)
|
2001-12-07 |
2009-05-29 |
포항공과대학교 산학협력단 |
ＳＩＶｍａｃ239의 면역원성 플라스미드 및 이들을 함유한ＡＩＤＳ ＤＮＡ 백신
|
|
AU2003216502B2
(en)
|
2002-03-01 |
2008-04-10 |
Sloan-Kettering Institute For Cancer Research |
Prevention of recurrence and metastasis of cancer
|
|
US8927251B2
(en)
|
2002-10-07 |
2015-01-06 |
The University Of Chicago |
Targeting of herpes simplex virus to specific receptors
|
|
JP4999330B2
(ja)
|
2004-01-22 |
2012-08-15 |
株式会社ディナベック研究所 |
サイトメガロウイルスエンハンサーおよびニワトリβ−アクチンプロモーターを含むハイブリッドプロモーターを利用したマイナス鎖ＲＮＡウイルスベクターの製造方法
|
|
GB0406389D0
(en)
|
2004-03-22 |
2004-04-21 |
Istituto Superiore Di Sanito |
Recombinant herpes simplex virus and uses therefor
|
|
US7473418B2
(en)
|
2004-03-25 |
2009-01-06 |
Cell Genesys, Inc. |
Pan cancer oncolytic vectors and methods of use thereof
|
|
CA2577692C
(en)
|
2004-08-20 |
2014-05-06 |
Viralytics Limited |
Methods and compositions for treatment of hematologic cancers
|
|
WO2006050211A2
(en)
|
2004-10-28 |
2006-05-11 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain
|
|
WO2006074526A1
(en)
|
2005-01-17 |
2006-07-20 |
Viralytics Limited |
Method and composition for treatment of neoplasms
|
|
PL2002003T3
(pl)
|
2005-05-27 |
2016-06-30 |
Ospedale San Raffaele Srl |
Wektor genetyczny zawierający mi-RNA
|
|
ES2398918T3
(es)
|
2005-08-26 |
2013-03-22 |
Dupont Nutrition Biosciences Aps |
Un método y una ordenación para soportar verticalmente elementos de resistencia eléctrica pendientes
|
|
US8980246B2
(en)
|
2005-09-07 |
2015-03-17 |
Sillajen Biotherapeutics, Inc. |
Oncolytic vaccinia virus cancer therapy
|
|
US20080008686A1
(en)
|
2006-07-10 |
2008-01-10 |
The Brigham And Women's Hospital, Inc. |
Tetracycline repressor regulated oncolytic viruses
|
|
SI2049663T1
(sl)
|
2006-08-11 |
2015-12-31 |
Dow Agrosciences Llc |
Homologna rekombinacija, posredovana z nukleazo s cinkovim prstom
|
|
EP2125032A4
(en)
|
2007-02-20 |
2011-02-23 |
Mayo Foundation |
CANCER TREATMENT WITH VIRAL NUCLEIC ACID
|
|
US8586028B2
(en)
|
2007-05-09 |
2013-11-19 |
Board Of Supervisors Of Lousiana State University And Agricultural And Mechanical College |
Synthetic herpes simplex viruses type-1 for treatment of cancers
|
|
WO2008143875A1
(en)
|
2007-05-14 |
2008-11-27 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Targeted delivery of glycine receptors to excitable cells
|
|
WO2009111892A1
(en)
|
2008-03-14 |
2009-09-17 |
Ottawa Health Research Institute |
Microrna mediated oncolytic targeting
|
|
GB0807424D0
(en)
|
2008-04-23 |
2008-05-28 |
Isis Innovation |
Virus
|
|
EP2307033A4
(en)
|
2008-05-29 |
2012-06-13 |
Gen Hospital Corp |
USE OF ONCOLYTIC HERPESVIRUS FOR THE KILLING OF CANCER STEM CELLS
|
|
EP2700405B1
(en)
|
2008-05-29 |
2018-04-04 |
Alma Mater Studiorum -Universita' di Bologna |
Herpes simplex virus (HSV) with modified tropism, uses and process of preparation thereof
|
|
GB0810912D0
(en)
|
2008-06-13 |
2008-07-23 |
Inst Animal Health Ltd |
Vector
|
|
WO2010011961A2
(en)
|
2008-07-25 |
2010-01-28 |
University Of Georgia Research Foundation, Inc. |
Prokaryotic rnai-like system and methods of use
|
|
US20100076057A1
(en)
|
2008-09-23 |
2010-03-25 |
Northwestern University |
TARGET DNA INTERFERENCE WITH crRNA
|
|
WO2010054108A2
(en)
|
2008-11-06 |
2010-05-14 |
University Of Georgia Research Foundation, Inc. |
Cas6 polypeptides and methods of use
|
|
MX337838B
(es)
|
2008-11-07 |
2016-03-22 |
Dupont Nutrition Biosci Aps |
Secuencias de repetidos palindromicos cortos regularmente intercalados agrupados de bifidobacterias.
|
|
EP2406379A4
(en)
|
2009-03-13 |
2012-09-26 |
Egen Inc |
COMPOSITIONS AND METHODS FOR RELEASING BIOLOGICALLY ACTIVE RNA
|
|
US20100297072A1
(en)
|
2009-05-19 |
2010-11-25 |
Depinho Ronald A |
Combinations of Immunostimulatory Agents, Oncolytic Virus, and Additional Anticancer Therapy
|
|
WO2011119925A2
(en)
|
2010-03-25 |
2011-09-29 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Synthetic herpes simplex viruses for treatment of cancers
|
|
WO2011125469A1
(ja)
|
2010-04-09 |
2011-10-13 |
国立大学法人東京大学 |
マイクロrna制御組換えワクシニアウイルス及びその使用
|
|
US9593347B2
(en)
|
2010-04-16 |
2017-03-14 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-HSV receptors
|
|
WO2012006181A2
(en)
|
2010-06-29 |
2012-01-12 |
Mount Sinai School Of Medicine |
Compositions and methods for inhibiting oncogenic micrornas and treatment of cancer
|
|
CN103261213A
(zh)
|
2010-10-20 |
2013-08-21 |
杜邦营养生物科学有限公司 |
乳球菌CRISPR-Cas序列
|
|
KR102068107B1
(ko)
|
2011-04-27 |
2020-01-20 |
아미리스 인코퍼레이티드 |
게놈 변형 방법
|
|
WO2012164565A1
(en)
|
2011-06-01 |
2012-12-06 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for downregulating prokaryotic genes
|
|
EP2543734A1
(en)
|
2011-07-07 |
2013-01-09 |
Deutsches Krebsforschungszentrum |
Adeno-parvovirus chimera with enhanced oncolytical potential
|
|
EP2591796A1
(en)
|
2011-11-10 |
2013-05-15 |
Universität Zürich |
Combination medicament comprising IL-12 and an anti-CTLA-4 ligand for tumor therapy
|
|
US11951157B2
(en)
|
2011-10-11 |
2024-04-09 |
Universitat Zurich |
Methods of treating malignant tumour with IL-12 and anti-PD-1 antibody
|
|
CA3101783C
(en)
|
2011-10-11 |
2023-01-31 |
Universitat Zurich Prorektorat Mnw |
Combination medicament comprising il-12 and an agent for blockade of t-cell inhibitory molecules for tumour therapy
|
|
US20130156808A1
(en)
|
2011-11-22 |
2013-06-20 |
Stipan Jonjic |
Vaccine comprising beta-herpesvirus
|
|
GB201122458D0
(en)
|
2011-12-30 |
2012-02-08 |
Univ Wageningen |
Modified cascade ribonucleoproteins and uses thereof
|
|
US20140363469A1
(en)
*
|
2012-01-19 |
2014-12-11 |
Alnylam Pharmaceuticals, Inc. |
Viral attenuation and vaccine production
|
|
RU2650811C2
(ru)
|
2012-02-24 |
2018-04-17 |
Фред Хатчинсон Кэнсер Рисерч Сентер |
Композиции и способы лечения гемоглобинопатии
|
|
WO2013141680A1
(en)
|
2012-03-20 |
2013-09-26 |
Vilnius University |
RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX
|
|
US9637739B2
(en)
|
2012-03-20 |
2017-05-02 |
Vilnius University |
RNA-directed DNA cleavage by the Cas9-crRNA complex
|
|
CA2896282C
(en)
|
2013-01-04 |
2021-07-20 |
Cytomx Therapeutics, Inc. |
Compositions and methods for detecting protease activity in biological systems
|
|
KR20250012194A
(ko)
*
|
2013-06-17 |
2025-01-23 |
더 브로드 인스티튜트, 인코퍼레이티드 |
바이러스 구성성분을 사용하여 장애 및 질환을 표적화하기 위한 crispr-cas 시스템 및 조성물의 전달, 용도 및 치료 적용
|
|
JP6726824B2
(ja)
|
2013-07-17 |
2020-07-22 |
ユニヴァーシティ オヴ ピッツバーグ オヴ ザ コモンウェルス システム オヴ ハイアー エデュケーション |
効率的な遺伝子送達用途のための非毒性ｈｓｖベクター及びその製造のための補完細胞
|
|
CN106068326B
(zh)
|
2013-10-28 |
2021-06-18 |
联邦高等教育系统-匹兹堡大学 |
溶瘤性hsv载体
|
|
WO2015127501A1
(en)
|
2014-02-27 |
2015-09-03 |
Viralytics Limited |
Combination method for treatment of cancer
|
|
JP7348708B2
(ja)
*
|
2014-04-30 |
2023-09-21 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
組み合わせワクチン装置および癌細胞を殺滅する方法
|
|
DK3169341T3
(da)
|
2014-07-16 |
2019-08-05 |
Transgene Sa |
Onkolytisk virus til ekspression af immun-checkpoint-modulatorer
|
|
US10647964B2
(en)
|
2015-03-05 |
2020-05-12 |
Northwestern University |
Non-neuroinvasive viruses and uses thereof
|
|
US10083137B2
(en)
|
2015-04-02 |
2018-09-25 |
Atmel Corporation |
Peripheral interface circuit for serial memory
|
|
US9884704B2
(en)
|
2015-08-04 |
2018-02-06 |
Ernesto A. Aguero-Hernandez |
Clip-clamp with top lock device and method
|
|
US10210575B1
(en)
|
2015-08-12 |
2019-02-19 |
State Farm Mutual Automobile Insurance Company |
System and method of using an image object as a visual data container
|
|
RU2766200C1
(ru)
*
|
2015-10-01 |
2022-02-09 |
Хит Байолоджикс, Инк. |
Композиции и способы для соединения внеклеточных доменов типа i и типа ii в качестве гетерологичных химерных белков
|
|
JP6954648B2
(ja)
|
2015-10-19 |
2021-10-27 |
シージー オンコロジー， インコーポレイテッド |
併用療法による固形腫瘍又はリンパ系腫瘍の治療方法
|
|
CN108601802A
(zh)
|
2015-12-02 |
2018-09-28 |
纪念斯隆-凯特林癌症中心 |
塞尼卡谷病毒（svv）细胞受体靶向的肿瘤治疗
|
|
EA201891022A1
(ru)
*
|
2015-12-17 |
2019-01-31 |
Псайоксус Терапьютикс Лимитед |
Вирус, кодирующий антитело к комплексу tcr или фрагмент указанного антитела
|
|
EP3778881A1
(en)
|
2016-01-08 |
2021-02-17 |
Replimune Limited |
Modified oncolytic virus
|
|
RU2749050C2
(ru)
|
2016-01-27 |
2021-06-03 |
Онкорус, Инк. |
Онколитические вирусные векторы и их применение
|
|
PL3426271T3
(pl)
|
2016-03-10 |
2025-11-24 |
Cg Oncology, Inc. |
Sposoby leczenia guzów litych terapią skojarzoną
|
|
KR102211838B1
(ko)
|
2016-04-22 |
2021-02-03 |
임비라 컴퍼니 리미티드 |
암치료용 종양 용해성 단순 헤르페스 바이러스(oHSV) 절대 벡터 및 그 구조체의 구조
|
|
CN109475613B
(zh)
|
2016-06-14 |
2024-02-20 |
匹兹堡大学-属高等教育联邦体系 |
使癌细胞对胞毒免疫细胞攻击敏感的nkg2d活化配体蛋白表达
|
|
RU2021127872A
(ru)
*
|
2016-06-30 |
2021-11-09 |
Онкорус, Инк. |
Доставка терапевтических полипептидов посредством псевдотипированных онколитических вирусов
|
|
JP7200104B2
(ja)
|
2016-08-01 |
2023-01-06 |
ヴァイロジン バイオテック カナダ リミテッド |
免疫系刺激分子を発現する腫瘍溶解性単純ヘルペスウイルスベクター
|
|
WO2018027316A1
(en)
|
2016-08-09 |
2018-02-15 |
Alkayyal Almohanad |
Oncolytic rhabdovirus expressing il12
|
|
CN119614520A
(zh)
*
|
2016-08-29 |
2025-03-14 |
阿卡米斯生物公司 |
携带双特异性t细胞衔接器的腺病毒
|
|
WO2018049261A1
(en)
|
2016-09-09 |
2018-03-15 |
Icellhealth Consulting Llc |
Oncolytic virus expressing immune checkpoint modulators
|
|
US20190275092A1
(en)
|
2016-11-01 |
2019-09-12 |
Dnatrix, Inc. |
Combination therapy for treatment of brain cancers
|
|
US11298420B2
(en)
|
2016-12-21 |
2022-04-12 |
Memgen, Llc |
Armed oncolytic viruses
|
|
EP3565578A1
(en)
|
2016-12-21 |
2019-11-13 |
Memgen LLC |
Armed replication-competent oncolytic adenoviruses
|
|
GB201700350D0
(en)
|
2017-01-09 |
2017-02-22 |
Replimune Ltd |
Altered virus
|
|
AU2018301701A1
(en)
|
2017-07-14 |
2020-02-27 |
Elevatebio Technologies, Inc. |
Encapsulated polynucleotides and methods of use
|
|
AU2018306455A1
(en)
|
2017-07-26 |
2020-02-27 |
Virogin Biotech Canada Ltd |
Oncolytic viral vectors and uses thereof
|
|
EP3875119A4
(en)
|
2018-10-30 |
2022-08-31 |
The University of Tokyo |
ONCOLYTIC VIRUS FOR CANCER THERAPY
|
|
EP3941514A4
(en)
|
2019-03-20 |
2023-08-30 |
Turnstone Biologics Inc. |
ONCOLYTIC VIROTHERAPY BY HETEROLOGY SEQUENTIAL BOOSTER
|
|
WO2020186356A1
(en)
|
2019-03-20 |
2020-09-24 |
Turnstone Biologics Inc. |
Methods for inducing an immune response against neoantigens
|
|
CA3157063A1
(en)
|
2019-10-10 |
2021-04-15 |
Oncorus, Inc. |
Dual viruses and dual oncolytic viruses and methods of treatment
|
|
US20220409684A1
(en)
|
2019-11-18 |
2022-12-29 |
The Brigham And Women's Hospital, Inc. |
Codon optimized new generation regulatable fusogenic oncolytic herpes simplex virus type 1 virus and methods of use
|